OBJECTIVES: In late June 2020, a large outbreak of coronavirus disease 2019 (COVID-19) occurred at a sleep-away youth camp in Georgia, affecting primarily persons ≤21 years. We conducted a retrospective cohort study among campers and staff (attendees) to determine the extent of the outbreak and assess factors contributing to transmission. METHODS: Attendees were interviewed to ascertain demographic characteristics, known exposures to COVID-19 and community exposures, and mitigation measures before, during, and after attending camp. COVID-19 case status was determined for all camp attendees on the basis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results and reported symptoms. We calculated attack rates and instantaneous reproduction numbers and sequenced SARS-CoV-2 viral genomes from the outbreak. RESULTS: Among 627 attendees, the median age was 15 years (interquartile range: 12-16 years); 56% (351 of 627) of attendees were female. The attack rate was 56% (351 of 627) among all attendees. On the basis of date of illness onset or first positive test result on a specimen collected, 12 case patients were infected before arriving at camp and 339 case patients were camp associated. Among 288 case patients with available symptom information, 45 (16%) were asymptomatic. Despite cohorting, 50% of attendees reported direct contact with people outside their cabin cohort. On the first day of camp session, the instantaneous reproduction number was 10. Viral genomic diversity was low. CONCLUSIONS: Few introductions of SARS-CoV-2 into a youth congregate setting resulted in a large outbreak. Testing strategies should be combined with prearrival quarantine, routine symptom monitoring with appropriate isolation and quarantine, cohorting, social distancing, mask wearing, and enhanced disinfection and hand hygiene. Promotion of mitigation measures among younger populations is needed.
OBJECTIVES: In late June 2020, a large outbreak of coronavirus disease 2019 (COVID-19) occurred at a sleep-away youth camp in Georgia, affecting primarily persons ≤21 years. We conducted a retrospective cohort study among campers and staff (attendees) to determine the extent of the outbreak and assess factors contributing to transmission. METHODS: Attendees were interviewed to ascertain demographic characteristics, known exposures to COVID-19 and community exposures, and mitigation measures before, during, and after attending camp. COVID-19 case status was determined for all camp attendees on the basis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results and reported symptoms. We calculated attack rates and instantaneous reproduction numbers and sequenced SARS-CoV-2 viral genomes from the outbreak. RESULTS: Among 627 attendees, the median age was 15 years (interquartile range: 12-16 years); 56% (351 of 627) of attendees were female. The attack rate was 56% (351 of 627) among all attendees. On the basis of date of illness onset or first positive test result on a specimen collected, 12 case patients were infected before arriving at camp and 339 case patients were camp associated. Among 288 case patients with available symptom information, 45 (16%) were asymptomatic. Despite cohorting, 50% of attendees reported direct contact with people outside their cabin cohort. On the first day of camp session, the instantaneous reproduction number was 10. Viral genomic diversity was low. CONCLUSIONS: Few introductions of SARS-CoV-2 into a youth congregate setting resulted in a large outbreak. Testing strategies should be combined with prearrival quarantine, routine symptom monitoring with appropriate isolation and quarantine, cohorting, social distancing, mask wearing, and enhanced disinfection and hand hygiene. Promotion of mitigation measures among younger populations is needed.
Authors: Katherine A Auger; Samir S Shah; Troy Richardson; David Hartley; Matthew Hall; Amanda Warniment; Kristen Timmons; Dianna Bosse; Sarah A Ferris; Patrick W Brady; Amanda C Schondelmeyer; Joanna E Thomson Journal: JAMA Date: 2020-09-01 Impact factor: 56.272
Authors: Russell M Viner; Oliver T Mytton; Chris Bonell; G J Melendez-Torres; Joseph Ward; Lee Hudson; Claire Waddington; James Thomas; Simon Russell; Fiona van der Klis; Archana Koirala; Shamez Ladhani; Jasmina Panovska-Griffiths; Nicholas G Davies; Robert Booy; Rosalind M Eggo Journal: JAMA Pediatr Date: 2021-02-01 Impact factor: 16.193
Authors: James Hadfield; Colin Megill; Sidney M Bell; John Huddleston; Barney Potter; Charlton Callender; Pavel Sagulenko; Trevor Bedford; Richard A Neher Journal: Bioinformatics Date: 2018-12-01 Impact factor: 6.931
Authors: Adriana S Lopez; Mary Hill; Jessica Antezano; Dede Vilven; Tyler Rutner; Linda Bogdanow; Carlene Claflin; Ian T Kracalik; Victoria L Fields; Angela Dunn; Jacqueline E Tate; Hannah L Kirking; Tair Kiphibane; Ilene Risk; Cuc H Tran Journal: MMWR Morb Mortal Wkly Rep Date: 2020-09-18 Impact factor: 17.586
Authors: Clinton R Paden; Ying Tao; Krista Queen; Jing Zhang; Yan Li; Anna Uehara; Suxiang Tong Journal: Emerg Infect Dis Date: 2020-07-01 Impact factor: 6.883
Authors: Sarah L Silverberg; Bei Yuan Zhang; Shu Nan Jessica Li; Conrad Burgert; Hennady P Shulha; Vanessa Kitchin; Laura Sauvé; Manish Sadarangani Journal: BMC Pediatr Date: 2022-04-02 Impact factor: 2.125
Authors: Ruth A Karron; Maria Garcia Quesada; Elizabeth A Schappell; Stephen D Schmidt; Maria Deloria Knoll; Marissa K Hetrich; Vic Veguilla; Nicole Doria-Rose; Fatimah S Dawood Journal: JCI Insight Date: 2022-04-22
Authors: Victoria T Chu; Anna R Yousaf; Karen Chang; Noah G Schwartz; Clinton J McDaniel; Scott H Lee; Christine M Szablewski; Marie Brown; Cherie L Drenzek; Emilio Dirlikov; Dale A Rose; Julie Villanueva; Alicia M Fry; Aron J Hall; Hannah L Kirking; Jacqueline E Tate; Tatiana M Lanzieri; Rebekah J Stewart Journal: N Engl J Med Date: 2021-07-21 Impact factor: 91.245